Ryan Allway April 5th, 2021 App, Exclusive, Top News Many early cannabis companies were forced into vertical-integration due to regulatory constraints. While it may make sense for cultivators to create extracts, it doesn’t always make sense for them to own commercial kitchens for confections or bottling machines for beverages,... Read more
Ryan Allway March 19th, 2021 Psychedelics, Top News TORONTO, March 19, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce... Read more
Under the partnership with ERO, the Company will leverage its statewide distribution infrastructure to serve as the exclusive distributor of ERO’s diverse line of finished goods across multiple product categories—including cannabis vape cartridges, concentrates, extracts, pre-rolls, and flower—to Highlanders’ rapidly growing customer base of over 200 licensed retailers throughout California.... Read more
CLC Enters Sales and Marketing Phase Producing First Commercial Cannabis-Derived Crude Oil, and Introduces Two Extraction Specialists
December 23, 2020
Ryan Allway December 23rd, 2020 VANCOUVER, British Columbia, Dec. 23, 2020 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE:CLC) (FRANKFURT: CLB) is pleased to announce that it has produced its first batch of cannabis-derived crude oil produced using its Vitalis R-200-H-GMP-SS extraction system... Read more
MagicMed zielt mit dem Programm für pharmazeutische Derivate auf einen massiven Markt ab
December 23, 2020
Ryan Allway December 23rd, 2020 Exclusive, German, Psychedelics Der Markt für Psychedelika ist aufgrund des unentdeckten therapeutischen Potenzials psychedelischer Moleküle schwer zu berechnen. Die wissenschaftliche Gemeinschaft hat gezeigt, dass Psychedelika mehrere Milliarden-Dollar-Märkte im Bereich Gehirn und psychische Gesundheit behandeln können. MagicMed Industries zielt darauf ab, Teile beider Märkte zu... Read more
MagicMed Targets Massive Market with Pharmaceutical Derivatives Program
December 23, 2020
Ryan Allway December 23rd, 2020 App, Exclusive, Psychedelics, Top Story The psychedelics market is hard to calculate because of the undiscovered therapeutic potential of psychedelic molecules. The scientific community has shown that psychedelics could treat multiple multibillion-dollar markets in the brain and mental health space. MagicMed Industries positions itself... Read more
Psychedelics Production Challenges & Solutions
December 21, 2020
Ryan Allway December 21st, 2020 App, Exclusive, Psychedelics, Top News Psilocybin and other tryptamine-based compounds could become blockbuster therapeutics for the treatment of depression, post-traumatic stress disorder and other difficult to treat psychiatric conditions. While many clinical trials are underway, researchers are turning their attention toward the problem of... Read more
Christina Lake Cannabis Announces Genetic Databank With Portfolio of Over 100 Proprietary Strains for Outdoor Growth, and Total Inventory of 600,000+ Seeds
December 18, 2020
Ryan Allway December 18th, 2020 News, Top News VANCOUVER, British Columbia, Dec. 18, 2020 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE:CLC) (FRANKFURT: CLB) is pleased to announce that after its inaugural growing season in which the Company produced 32,500 kg / 71,650... Read more
Tryp Therapeutics Begins Trading on the Canadian Securities Exchange
December 18, 2020
Ryan Allway December 18th, 2020 Psychedelics, Top News La Jolla, CA – December 18, 2020 – Tryp Therapeutics Inc. (“Tryp” or the “Company”) (CSE: TRYP) is pleased to announce that the Company’s common shares have commenced trading on the Canadian Securities Exchange (“CSE”) under the symbol “TRYP” effective December 18, 2020.... Read more
Innovation zahlt sich aus bei Psychedelika
December 18, 2020
Es besteht ein erhebliches Interesse am psychedelischen Bereich und an den vielversprechenden psychedelischen Molekülen für die Behandlung von psychischen Erkrankungen. Geisteskrankheiten sind eine allgegenwärtige menschliche Erfahrung und eine bisher nur unzureichend behandelte medizinische Notwendigkeit. Psychedelika bieten eine Alternative zu unwirksamen Behandlungen, da sie über andere Wirkmechanismen funktionieren. Psychedelische Arzneimittel... Read more
